CR Capital Mulls Buying Control of Plasma Firm Boya

(Bloomberg) -- China Resources Capital Management Ltd. is considering acquiring a controlling stake in Shenzhen-listed Boya Bio-Pharmaceutical Group Co., according to people familiar with the matter.